Related Experiment Video
Updated: Jul 4, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Shuangshuang Zhao1, Yan Guo1, Xunzhe Yin2
1School of Clinical Medicine, Changchun University of Chinese Medicine, 130117 Changchun, Jilin, China.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. The prevalence of MASLD has been increasing, mirroring the global increase in diabetes and metabolic syndrome. MASLD is a chronic and progressive condition characterized by inflammation, oxidative stress, insulin resistance, and disruptions in lipid metabolism. Programmed cell death (PCD) plays a pivotal role in determining the pathological aspects of MASLD, including liver inflammation, fibrosis, and even the potential for malignant transformation. PCD is a dominant process that is fundamental for eukaryotic growth and serves as a regulatory factor in MASLD. PCD encompasses various pathways, including autophagy, ferroptosis, apoptosis, and pyroptosis. These PCD pathways can be activated at different stages of MASLD. The key effector molecules involved in these processes are central focal points in the development of therapeutic interventions for MASLD. Here, we comprehensively review the idea that targeted the modulation of the PCD pathway may be an effective approach for the prevention and/or treatment of MASLD.
Insights
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects 25% globally. Targeting programmed cell death (PCD) pathways offers a promising therapeutic strategy for MASLD prevention and treatment.
Area of Science:
- Hepatology
- Cell Biology
- Metabolic Diseases
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition with increasing global incidence.
- MASLD is characterized by liver inflammation, oxidative stress, insulin resistance, and lipid metabolism disruptions.
- MASLD is a leading cause of cirrhosis and hepatocellular carcinoma.
Purpose of the Study:
- To review the role of programmed cell death (PCD) in MASLD pathogenesis.
- To explore the potential of modulating PCD pathways as a therapeutic strategy for MASLD.
Main Methods:
- Comprehensive literature review on MASLD and PCD pathways.
- Analysis of the involvement of autophagy, ferroptosis, apoptosis, and pyroptosis in MASLD.
- Identification of key effector molecules in PCD pathways relevant to MASLD.
Main Results:
- Programmed cell death (PCD) is a critical regulator in MASLD progression, influencing liver inflammation, fibrosis, and malignant transformation.
- Multiple PCD pathways, including autophagy, ferroptosis, apoptosis, and pyroptosis, are activated during MASLD.
- Specific effector molecules within these PCD pathways are potential therapeutic targets.
Conclusions:
- Targeting programmed cell death (PCD) pathways presents a viable therapeutic approach for MASLD.
- Modulation of PCD may prevent or treat MASLD and its complications.
- Further research into PCD effectors could lead to novel MASLD treatments.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

